MedPath

Study to evaluate serum magnesium levels in people with type 2 Diabetes mellitus and its relation with blood sugar control and complications of Diabetes mellitus involving kidney, eyes and the nerves.

Not Applicable
Conditions
Health Condition 1: E112- Type 2 diabetes mellitus with kidney complicationsHealth Condition 2: E114- Type 2 diabetes mellitus with neurological complicationsHealth Condition 3: E113- Type 2 diabetes mellitus with ophthalmic complicationsHealth Condition 4: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2019/06/019657
Lead Sponsor
Dr Alan Kurian
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients with type 2 Diabetes mellitus

Exclusion Criteria

1. Pregnant women/Lactating mothers

2. Patients with diabetes mellitus other than type 2

3. Patients shifted out from ICU

4. Critically ill patients including patients with significant hepatic and renal disease, CKD, MI

5. Patients receiving magnesium supplements or diuretics

6. Patients with history of chronic alcohol abuse

7. Patients with malabsorbtion or chronic diarrhoea

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath